ecancer

The Cancer Genome Atlas

Dr Douglas Levine - Memorial Sloan-Kettering Cancer Center

7 Dec 2010

CA-125 in the follow up of patients with ovarian cancer

Prof Christian Marth - Innsbruck Medical University, Austria

7 Dec 2010

The role of trabectedin in the treatment of ovarian cancer

Prof Bradley Monk - University of California at Irvine, USA

7 Dec 2010

Bevacizumab as part of standard first line treatment of ovarian cancer

Prof Jonathan Ledermann - University College London, UK

10 Nov 2010

GOG-218: Bevacizumab plus standard chemo for ovarian cancer

Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA

10 Nov 2010

The ICON7 trial

Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK

1 Nov 2010

ESTRO 2010 - Snapshots from the conference

European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-16th September 2010

25 Oct 2010

The role of ESTRO in the development of gynaecological cancer treatment

Prof Richard Pötter - Medical University of Vienna, Austria

6 Oct 2010

ESTRO 2010 Highlights

Professor Gordon McVie - European Institute of Oncology

6 Oct 2010

The rise in rates of endometrial cancer

Dr Paul Cornes, Bristol Oncology Centre, UK

3 Aug 2010

Optimising adjuvant therapy in the treatment of early stage endometrial cancer patients

Dr Carien Creutzberg - Leiden University Medical Center, Netherlands

2 Aug 2010

Key advances in ovarian cancer from ASCO 2010

Dr Prof Jonathan Ledermann - UCL Cancer Institute, UK

22 Jul 2010

More from ecancer